Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
(–)-Thalidomide is an active enantiomer of (±)-thalidomide (Item No. 14610) and has immunomodulatory and teratogenic activities.1,2,3 It enhances TNF-α production induced by phorbol 12-myristate 13-acetate (TPA; Item No. 10008014) in HL-60 cells when used at concentrations ranging from 0.1 to 100 µM.1 Preincubation of isolated Rhode Island Red (RIR) chicken donor blood with (–)-thalidomide (10 mg/ml) reduces recipient chicken embryo splenomegaly in a model of graft versus host disease.2 (–)-Thalidomide (150 mg/kg) induces fetal malformations when administered to pregnant female rabbits.3
WARNING This product is not for human or veterinary use.
1. (S)-
2. Effect of thalidomide on the graft versus host reaction. Nature 211(5055), 1308-1310 (1966).
3. Toxicity and teratogenicity of optical isomers of thalidomide. Nature 215(5098), 296 (1967).